The Geisinger MyCode community health initiative: An electronic health record-linked biobank for precision medicine research

Genetics in Medicine

Volumn 18, Issue 9, 2016, Pages 906-913

  Carey, David J ^a   Fetterolf, Samantha N ^a   Davis, F Daniel ^a   Faucett, William A ^a   Kirchner, H Lester ^a   Mirshahi, Uyenlinh ^a   Murray, Michael F ^a   Smelser, Diane T ^a   Gerhard, Glenn S ^b   Ledbetter, David H ^a  

^a GEISINGER HEALTH SYSTEM   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biobank; electronic health records; genetic association; genomics

Indexed keywords

BIOBANK; CLINICAL RESEARCH; ELECTRONIC HEALTH RECORD; EXOME; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MODEL; PERSONALIZED MEDICINE; PHENOTYPE; PUBLIC HEALTH; TRANSLATIONAL RESEARCH; MEDICAL RESEARCH;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; ELECTRONIC HEALTH RECORDS; GENOTYPE; HUMANS; PHENOTYPE; PRECISION MEDICINE; PUBLIC HEALTH;

EID: 84984945132     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.187     Document Type: Article

References (32)

1. Slotkin JR, Casale AS, Steele GD Jr, Toms SA. Reengineering acute episodic, and chronic care delivery: the Geisinger Health System experience. Neurosurg Focus 2012; 33: E16
2. Paulus RA, Davis K, Steele GD. Continuous innovation in health care: implications of the Geisinger experience. Health Aff (Millwood) 2008; 27: 1235-1245
3. Casale AS, Paulus RA, Selna MJ, et al. "ProvenCareSM": a provider-driven payfor-performance program for acute episodic cardiac surgical care. Ann Surg 2007; 246: 613-21; discussion 621
4. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015; 372: 793-795
5. Precision Medicine Initiative. www.nih.gov/precisionmedicine. Updated 2015
6. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491-1493
7. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases, and 3,000 shared controls. Nature 2007; 447: 661-678
8. Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm, and intracranial aneurysm. Nat Genet 2008; 40: 217-224
9. Samani NJ, Erdmann J, Hall AS, et al. WTCCC, and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443-453
10. Schunkert H, Götz A, Braund P, et al. Cardiogenics Consortium. Repeated replication, and a prospective meta-analysis of the association between chromosome 9p21.3, and coronary artery disease. Circulation 2008; 117: 1675-1684
11. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-323
12. Groves CJ, Zeggini E, Minton J, et al. Association analysis of 6,736 U.K. subjects provides replication, and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006; 55: 2640-2644
13. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-2163
14. Florez JC, Jablonski KA, Bayley N, et al. Diabetes Prevention Program Research Group. TCF7L2 polymorphisms, and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355: 241-250
15. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index, and predisposes to childhood, and adult obesity. Science 2007; 316: 889-894
16. Hunt SC, Stone S, Xin Y, et al. Association of the FTO gene with BMI. Obesity (Silver Spring) 2008; 16: 902-904
17. Loos RJ, Lindgren CM, Li S, et al. Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial; KORA; Nurses? Health Study; Diabetes Genetics Initiative; SardiNIA Study; Wellcome Trust Case Control Consortium; FUSION. Common variants near MC4R are associated with fat mass, weight, and risk of obesity. Nat Genet 2008; 40: 768-775
18. Qi L, Kraft P, Hunter DJ, Hu FB. The common obesity variant near MC4R gene is associated with higher intakes of total energy, and dietary fat, weight change, and diabetes risk in women. Hum Mol Genet 2008; 17: 3502-3508
19. Renström F, Payne F, Nordström A, et al. GIANT Consortium. Replication, and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet 2009; 18: 1489-1496
20. TG, and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute; Crosby J, Peloso GM, Auer PL, et al. Loss-offunction mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 2014; 371: 22-31
21. Pollin TI, Damcott CM, Shen H, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile, and apparent cardioprotection. Science 2008; 322: 1702-1705
22. Mirshahi T, Murray MF, Carey DJ. The metabolic syndrome, and DYRK1B. N Engl J Med 2014; 371: 784-785
23. Crawford DC, Crosslin DR, Tromp G, et al. eMERGEing progress in genomics-the first seven years. Front Genet 2014; 5: 184
24. Gottesman O, Kuivaniemi H, Tromp G, et al. eMERGE Network. The Electronic Medical Records, and Genomics (eMERGE) Network: past, present, and future. Genet Med 2013; 15: 761-771
25. McCarty CA, Chisholm RL, Chute CG, et al. eMERGE Team. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011; 4: 13
26. Olson JE, Bielinski SJ, Ryu E, et al. Biobanks, and personalized medicine. Clin Genet 2014; 86: 50-55
27. Olson JE, Ryu E, Johnson KJ, et al. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc 2013; 88: 952-962
28. Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle, and old age. PLoS Med 2015; 12: e1001779
29. Kang B, Park J, Cho S, et al. Current status, challenges, policies, and bioethics of biobanks. Genomics Inform 2013; 11: 211-217
30. Tomlinson T, De Vries R, Ryan K, Kim HM, Lehpamer N, Kim SY. Moral concerns, and the willingness to donate to a research biobank. JAMA 2015; 313: 417-419
31. Rahm AK, Wrenn M, Carroll NM, Feigelson HS. Biobanking for research: a survey of patient population attitudes, and understanding. J Community Genet 2013; 4: 445-450
32. Institute of Medicine. The learning healthcare system. Workshop summary. olsen L, Aisner D, McGinnis JM, eds. http://www.iom.edu/Reports/2007/The-Learning-Healthcare-System-Workshop-Summary.aspx. Updated 2007